LY354740, an agonist of glutamatergic metabotropic receptor mGlu2/3 increases the cytochrome P450 2D (CYP2D) activity in the frontal cortical area of rat brain

Ewa Bromek, Anna Haduch, Renata Pukło, Władysława A Daniel · 2024

Read LY354740, an agonist of glutamatergic metabotropic receptor mGlu2/3 increases the cytochrome P450 2D (CYP2D) activity in the frontal cortical area of rat brain by Ewa Bromek, Anna Haduch, Renata Pukło, Władysława A Daniel (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11582139.txt.

Description

Bromek and three co-authors study a drug's effect on a brain enzyme in rats in this two thousand twenty-four paper. The enzyme, CYP2D, helps process brain chemicals and some medicines. Earlier work from the group hinted that brain glutamate systems can sway this enzyme. Here they test a compound that activates a glutamate receptor pair called mGlu2/3. The compound is known as LY354740.

They measured the enzyme's activity and protein levels in the brain and liver. The drug raised CYP2D activity in the frontal cortex of the rat brain. Such a finding links a mood-related receptor system to local drug metabolism in the brain. That link could matter for how psychiatric drugs act. The work is basic animal research, meant to guide later studies.

Catalog record

CREATOREwa Bromek, Anna Haduch, Renata Pukło, Władysława A Daniel
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE20 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11582139

Browse the full library · About the Tower of Babel